The study of role of HbA1c as a predictor of gestational diabetes mellitus

Nikita Shrivastava, Kanchan Durugkar, Pallavi Viswanadh, Himadri Bal


Background: India is the diabetic capital of the world and gestational diabetes mellitus contributes to a significant number of cases. Gestational diabetes mellitus is a common medical complication of pregnancy and may lead to serious consequences. Because of these reasons, it was felt that if there was a biomarker for predicting carbohydrate intolerance in pregnancy, it could help in earlier intervention and mitigate the consequences related to it. Hence, for this purpose, the role of HbA1c was studied as a predictor of gestational diabetes mellitus.

Methods: This was a cross sectional study. Five hundred antenatal cases were considered for this study. All antenatal patients before 18 weeks of gestation attending antenatal clinic for the first time were selected and these patients were subjected to HbA1c followed by diabetes in pregnancy study group of India (DIPSI) test between 24-28 weeks and the results were analyzed to find any correlation between the two.

Results: The main objective of the present study was to find whether HbA1c can be used as a predictor of gestational diabetes mellitus. In this study out of 500 women screened, 60 women turned out to have gestational diabetes mellitus. When comparing DIPSI positivity with various levels of HbA1c, it was found that maximum number of DIPSI positive patients (93.33%), had raised HbA1c levels.

Conclusions: Maximum number of DIPSI positive cases had HbA1c level between 5.5 to 6 and this association was found to be statistically significant and a positive correlation was established between the two.


Diabetes in pregnancy study group of India, Gestational diabetes mellitus, HbA1c, Predictor, Screening, Significant correlation

Full Text:



American Diabetes Association. Gestational Diabetes Mellitus. Diabetes Care. 2002;25(suppl 1):s94-s96.

Getahun D, Nath C, Ananth CV, Chavez MR, Smulian JC. Gestational diabetes in the United States: temporal trends 1989 through 2004. Am J Obstet Gynecol. 2008;198:525.e1-525.e5.

O’Sullivan JB, Mahan CB. Criteria for oral glucose tolerance test in pregnancy. Diabetes. 1964;13:278.

Geneva: World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications Report of a WHO Consultation, Part 1: Diagnosis and Classification of Diabetes Mellitus; 1999:1-59.

Anjalakshi C, Balaji V, Balaji MS, Ashalata S, Suganthi S, Arthi T, et al. A single test procedure to diagnose gestational diabetes mellitus. Acta Diabetol. 2009;46:51-4.

Seshiah V, Das AK, Balaji V, Joshi SR, Parikh MN, Gupta S. Diabetes in pregnancy study group. gestational diabetes mellitus - Guidelines. J Assoc Physicians India. 2006;54:622-8.

Miedema K. Standardization of HbA1c and optimal range of monitoring. Scand J Clin Lab Invest. 2005;240:61-72.

Koenig RJ, Peterson CM, Jones RL, Saudek C, Lehrman M, Cerami A. Correlation of glucose regulation and hemoglobin A1c in diabetes mellitus. N Engl J Med. 1976;295:417-20.

Renz PB, Cavagnolli G, Weinert LS, Silveiro SP, Camargo JL. HbA1c test as a tool in the diagnosis of gestational diabetes mellitus. PLoS One. 2015;10(8):e0135989.

Khalafallah A, Phuah E, Al-Barazan AM, Nikakis I, Radford A, Clarkson W, et al. Glycosylated haemoglobin for screening and diagnosis of gestational diabetes mellitus. BMJ Open. 2016;6,e011059.

Ye M, Liu Y, Cao X, Yao F, Liu B, Li Y, et al. The utility of HbA1c for screening gestational diabetes mellitus and its relationship with adverse pregnancy outcomes. Diabetes Res Clin Pract. 2016 ;114:43-9.

Wu K, Cheng Y, Li T, Ma Z, Liu J, Zhang Q, et al. Utility of HbA1c combined with hematocrit for early screening of gestational diabetes mellitus. Diabetol Metabol Syndrome. 2018;10:14.

Ho YR, Wang P, Lu MC, Tseng ST, Yang CP, Yan YH. Associations of mid-pregnancy HbA1c with gestational diabetes and risk of adverse pregnancy outcomes in high-risk Taiwanese women. PloS one. 2017 May 15;12(5):e0177563.